In consideration of the high mutation/deletion rate of the BRCA1 gene in human breast and ovarian cancers, the NBR2 gene, which is proximal to the BRCA1 gene, was initially presumed to be co-deleted/mutated with BRCA1 in certain cancers. The gene discussed is BRCA1; the disease is ovarian carcinoma.